Diagnostics Product and Service Provider MedTest Dx Unveils New Corporate Name Reinforcing Its Integrated Model that Better Serves Customers

Company Growth Reflects Its Seamless Integration of Multiple Established Diagnostics Brands Known for Quality, Customer Service and Innovation

 

—Learn More About How MedTest Dx’s Integrated Offerings Can Advance Your               Clinical Laboratory Testing at AACC 2018 Booth #4516—

 

Canton MI, July 26, 2018 – MedTest Holdings, the solution provider of choice offering integrated products and services for decentralized clinical diagnostic testing, today announced the debut of its new corporate name—MedTest Dx—at the upcoming 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting in Chicago, IL. MedTest Dx is a rapidly growing company that is uniquely positioned to service the decentralized testing community through its comprehensive portfolio of diagnostic products and services that seamlessly integrates screening instruments, reagent development and manufacturing, toxicology confirmation products and world-class service.

 

To meet the specialized scientific and regulatory needs of its varied customers, MedTest Dx has assembled and combined four respected brands--globally-recognized reagent provider Pointe Scientific; the Medical Laboratories Solutions (MLS) service organization known for customer advocacy and excellence in chemistry, toxicology, and hematology support; MedTest Dx’s reliable, scalable, state-of-the-art laboratory instrumentation; and Clinitox Diagostix’s capabilities in drugs of abuse screening and confirmation. Through its multiple locations in Canton, MI; Fletcher, NC and Mississauga, Canada, MedTest Dx delivers a large, diversified portfolio of customizable, quality diagnostic products and services designed to enhance the clinical laboratory testing of its diverse customer base, with the goal of helping them grow their business and achieve their laboratory's full potential.

 

Wayne Brinster, Chief Executive Officer of MedTest Dx, commented, “Our goal in integrating these leading diagnostic brands to create MedTest Dx was to offer a comprehensive high-quality solution that enables our clinical lab customers to provide decentralized clinical testing services efficiently and cost-effectively. We are proud of the breadth and excellence of our integrated mix of products and services and of the customer focus that informs everything we do. We are excited to introduce our new company name at the AACC meeting and look forward to welcoming returning and new customers and friends to Booth #4516. Come and learn more about the many ways that MedTest Dx can strengthen your clinical laboratory testing.”

 

MedTest Dx’s quality standards include FDA registration, 510(k) approval and CLIA classification, ISO 13485, GMP, USDA annual inspection for TRACES database, CMDCS, and CE Certification and Declaration of Conformity.

 

The company that is now MedTest Dx began with the 2011 purchase of Polymedco’s chemistry product line. The addition of Pointe Scientific brought high quality reagents, calibrators and controls, enzyme immunoassays and specialty assays to the new firm. The acquisition of Clinitox Diagostix added capabilities in drugs of abuse testing, enabling confirmation tests via LC/MS instrumentation, reagents and consumables. By acquiring Medical Laboratories Solutions (MLS), MedTest Dx gained a highly regarded clinical diagnostic laboratory service offering to complement and support the company’s instruments, assays and reagents.

 

To learn more about how MedTest Dx’s integrated solutions can strengthen and support clinical laboratory services, visit AACC 2018 Booth #4516.

 

About MedTest Dx                                                                                                        

MedTest Dx is purpose built to be the Solution Provider of Choice for decentralized clinical testing. We offer a unique combination of screening instruments, reagent manufacturing, world-class service capabilities and full LC/MS toxicology confirmation products. We are a globally-recognized reagent manufacturing organization meeting scientific and regulatory needs as well as a service organization with an impeccable reputation in chemistry, toxicology and hematology. Working within laboratories’ budgetary constraints, we can customize reliable, scalable, state-of-the-art, low-cost testing solutions that best meet the needs of all our customers. We challenge ourselves every day with the question - “What Would our Customers Want?” Through this relentless customer advocacy, we strive to deliver the best solutions to customers’ daily challenges. For more information, visit www.medtestdx.com.

 

                                                                        ###

 

 

Contacts

MedTest Dx                                                                 Media

Tracy Luciano                                                               Brandwidth Solutions LLC         
Phone  856.982.2168                                                    Debra Harrsch 

Email   tluciano@medtest.com                                       Phone   267.577.0806                                                                         Email           dharrsch@BWSmarketing.com

 

                                                      

 

 

 

 

 

Shannon Daley